A PYMNTS Company

US: FTC clarifies rules of pharma patent buyouts

By  |  November 6, 2013

The US Federal Trade Commission has reportedly issued its final amendments to legislation outlining the requirements of companies that acquire pharmaceutical patents to report that acquisition to the FTC and the Department of Justice, according to reports.

The regulator has clarified when such deals need to be notified under the premerger notification program. According to reports, the FTC and DOJ worked together to amend the current guidelines that will now become effective 30 days following publication.

Full content: 4-Traders

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.